Please login to the form below

Not currently logged in
Email:
Password:

Activartis

This page shows the latest Activartis news and features for those working in and with pharma, biotech and healthcare.

FDA grants orphan status to Activartis’ brain cancer immunotherapy

FDA grants orphan status to Activartis’ brain cancer immunotherapy

Activartis' AV0113 is part of this growing trend, and the drug has shown promise in early-stage trials. ... time. According to Activartis, preliminary results revealed a “very promising trend” towards overall survival benefit in patients taking AV0113

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics